Prestige Consumer Healthcare
PBH
#4828
Rank
A$3.05 B
Marketcap
A$64.50
Share price
-1.78%
Change (1 day)
-30.48%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2023 (TTM): A-$2.38

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$4.76. In 2022 the company made an earnings per share (EPS) of A$6.13 an increase over its 2021 EPS that were of A$5.49.

EPS history for Prestige Consumer Healthcare from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$2.38-138.86%
2022A$6.1311.7%
2021A$5.4913.6%
2020A$4.83-651.67%
2019A-$0.88-148.78%
2018A$1.80-83.29%
2017A$10.75437.23%
2016A$2.00-34.13%
2015A$3.0452.94%
2014A$1.99-8.11%
2013A$2.1662.64%
2012A$1.334.6%
2011A$1.2770.59%
2010A$0.74-113.97%
2009A-$5.33-621.43%
2008A$1.027.69%
2007A$0.951.56%
2006A$0.93-681.82%
2005A-$0.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.75 104.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$9.87 107.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.67 61.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.04-78.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$3.95-17.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$7.11 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$4.67-1.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.20-11.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$43.25-1,008.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.78-62.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel